-
Neuromon B.V. is a small Dutch company aiming to promote the use of Transcranial Doppler for neuromuscular monitoring, for instance, on the intensive care.
-
The company is based upon three pillars: a new hypothesis on cardiovascular function, a computer model simulating this hypothesis and an international patent on the Pulsatile apparent Resistance: a numerical index relating blood flow velocity measurements with arterial blood pressure.
-
Based upon a new hypothesis on cardiovascular function Neuromon B.V. has developed software for an improved analysis of the Transcranial Doppler signal: discriminating two systolic peaks. This analysis is in line with the theory of arterial acceleration.
-
In order to bring Neuromon's innovations available to the market, the company has joined forces with Compumedics DWL, an important manufacturer of Transcranial Doppler equipment based in Germany.